OXiGENE, Inc. (OXGN) Stock Ratings

Other Member Ratings

View Most Rated Stocks

Member	Call	Date Rated	Timeframe	Start Price	End Price	Stock Gain/Loss	Score	Status
andrea dardi		10/19/2012	1 Year	$0.47	$3.11	+561.7%	561	Active
Comments: VDA are the only possible cure for large solid cancers, where genetic inhibitors don't work
deanrusk		10/10/2012	3 months	$0.53	$4.32	+722.7%	722	Ended
Comments: Could be a diamond in the rough,but be careful here. Reverse split might be coming..
sandor baksa		08/11/2011	3 months	$1.60	$0.56	-65%	-65	Ended
Comments: This stock is undervalued
CRodriguez		05/13/2011	3 months	$5.53	$0.56	-89.87%	-89	Ended
Comments: Industry sector growing or poised for growth
Forskare		02/15/2011	3 months	$0.17	$0.56	+229.41%	229	Ended
Comments: This stock is undervalued
Tiege		02/14/2011	3 months	$0.16	$0.56	+250%	250	Ended
Comments: Upcoming product launch will be successful
Jöns		12/22/2009	3 months				N/A	Ended
Comments: An extremely underpriced stock with very promising future products where we soon will see a short squeeze seldom seen before!! A more correct stock price would be 2 – 2,50$/share.

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.